CHEBI:16117 - β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group
ChEBI ID CHEBI:16117
ChEBI ASCII Name beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group
Definition An N-acetyl-D-galactosaminyl group in which D-Gal is linked β(1→3) to the D-GalNAc group which has α-configuration at its anomeric centre.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:10387, CHEBI:12361, CHEBI:22785
Download Molfile XML SDF
Formula C14H24NO10
Net Charge 0
Average Mass 366.34110
Monoisotopic Mass 366.14002
SMILES [C@@H]1([C@H](O[C@@H]([C@@H]([C@@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)CO)*)NC(=O)C
Roles Classification
Biological Role(s): epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group (CHEBI:16117) has role epitope (CHEBI:53000)
β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group (CHEBI:16117) is a N-acetyl-D-galactosaminyl group (CHEBI:21507)
β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group (CHEBI:16117) is substituent group from β-D-Gal-(1→3)-α-D-GalNAc (CHEBI:61820)
IUPAC Name
β-D-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-α-D-galactopyranosyl
Synonyms Sources
2-acetamido-2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranosyl JCBN
β-D-Gal-(1→3)-α-D-GalNAc-yl group ChEBI
β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl ChEBI
β-D-galactosyl-1,3-N-acetyl-α-D-galactosaminyl group ChEBI
beta-D-Galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-R KEGG COMPOUND
β-Gal-(1→3)-α-GalNAc-R ChEBI
Gal-(β1,3)-GalNAc- ChEBI
Galβ1-3GalNAcα- ChEBI
Manual Xrefs Databases
C04750 KEGG COMPOUND
G00024 KEGG GLYCAN
View more database links
Citations Waiting for Citations Types Sources
11530204 PubMed citation Europe PMC
17988798 PubMed citation Europe PMC
26014598 PubMed citation Europe PMC
33643275 PubMed citation Europe PMC
Last Modified
31 March 2021